CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	12 Months Ended
	Jan. 31, 2015	Jan. 31, 2014	Jan. 31, 2013
CASH FLOWS FROM OPERATING ACTIVITIES:
Net earnings	$ 484,179,000	$ 181,369,000	$ 416,157,000
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	194,158,000	180,629,000	163,649,000
Amortization of gain on sale-leasebacks	(9,156,000)	(9,453,000)	(10,812,000)
Excess tax benefits from share-based payment arrangements	(14,111,000)	(14,876,000)	(11,763,000)
Provision for inventories	33,620,000	31,667,000	32,228,000
Deferred income taxes	37,712,000	(27,855,000)	(19,282,000)
Provision for pension/postretirement benefits	39,234,000	48,980,000	46,008,000
Share-based compensation expense	26,451,000	32,188,000	26,938,000
Changes in assets and liabilities:
Accounts receivable	(17,561,000)	(23,239,000)	(1,393,000)
Inventories	(167,607,000)	(168,273,000)	(233,700,000)
Prepaid expenses and other current assets	(20,864,000)	(14,654,000)	(22,121,000)
Other assets, net	(20,180,000)	(21,333,000)	(4,561,000)
Accounts payable and accrued liabilities	(5,927,000)	45,413,000	(13,680,000)
Income taxes payable	81,890,000	(70,143,000)	(16,559,000)
Merchandise and other customer credits	(2,739,000)	4,711,000	1,640,000
Other long term liabilities	(23,982,000)	(20,479,000)	(24,459,000)
Net cash provided by operating activities	615,117,000	154,652,000	328,290,000
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of marketable securities and short-term investments	(40,063,000)	(23,460,000)	(15,226,000)
Proceeds from sale of marketable securities and short-term investments	55,308,000	0	19,289,000
Capital expenditures	(247,394,000)	(221,452,000)	(219,530,000)
Notes receivable funded	0	(3,050,000)	(8,015,000)
Proceeds from notes receivable	15,160,000	1,181,000	0
Payments to acquire intangible assets	0	0	(82,664,000)
Payment for acquisition	0	0	(25,000,000)
Net cash used in investing activities	(216,989,000)	(246,781,000)	(331,146,000)
CASH FLOWS FROM FINANCING ACTIVITIES:
(Repayments of) proceeds from credit facility borrowings, net	(12,454,000)	49,883,000	47,278,000
Proceeds from other credit facility borrowings	19,803,000	89,806,000	40,298,000
Repayment of other credit facility borrowings	(3,412,000)	(69,737,000)	(361,000)
Proceeds from issuance of long-term debt	548,037,000	0	250,000,000
Repayment of long-term debt	(400,000,000)	0	(60,000,000)
Payment for settlement of interest rate swaps	(4,180,000)	0	(29,335,000)
Repurchase of Common Stock	(27,028,000)	0	(54,107,000)
Proceeds from exercised stock options	42,902,000	27,895,000	13,012,000
Excess tax benefits from share-based payment arrangements	14,111,000	14,876,000	11,763,000
Cash dividends on Common Stock	(191,171,000)	(170,312,000)	(158,594,000)
Proceeds from non-controlling interest	0	0	12,750,000
Distribution to non-controlling interest	(1,910,000)	(666,000)	0
Financing fees	(8,073,000)	(7,171,000)	(1,258,000)
Net cash (used in) provided by financing activities	(23,375,000)	(65,426,000)	71,446,000
Effect of exchange rate changes on cash and cash equivalents	9,426,000	(1,505,000)	2,294,000
Net increase/(decrease) in cash and cash equivalents	384,179,000	(159,060,000)	70,884,000
Cash and cash equivalents at beginning of year	345,778,000	504,838,000	433,954,000
Cash and cash equivalents at end of year	$ 729,957,000	$ 345,778,000	$ 504,838,000